Unknown

Dataset Information

Preliminary outcomes of preemptive warfarin pharmacogenetic testing at a large rural healthcare center.


ABSTRACT:

Purpose

As a preliminary evaluation of the outcomes of implementing pharmacogenetic testing within a large rural healthcare system, patients who received pre-emptive pharmacogenetic testing and warfarin dosing were monitored until June 2017.

Summary

Over a 20-month period, 749 patients were genotyped for VKORC1 and CYP2C9 as part of the electronic Medical Records and Genomics Pharmacogenetics (eMERGE PGx) study. Of these, 27 were prescribed warfarin and received an alert for pharmacogenetic testing pertinent to warfarin; 20 patients achieved their target international normalized ratio (INR) of 2.0-3.0, and 65% of these patients achieved target dosing within the recommended pharmacogenetic alert dose (± 0.5 mg/day). Of these, 10 patients had never been on warfarin prior to th

SUBMITTER: Leary E 

PROVIDER: S-EPMC6479622 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature